Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Adaptation to Extreme Environments in an Admixed Human Population from the Atacama Desert.

Vicuña L, Fernandez MI, Vial C, Valdebenito P, Chaparro E, Espinoza K, Ziegler A, Bustamante A, Eyheramendy S.

Genome Biol Evol. 2019 Sep 1;11(9):2468-2479. doi: 10.1093/gbe/evz172.

2.

Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.

López R, Vial C, Graf J, Calvo M, Ferrés M, Mertz G, Cuiza A, Agüero B, Aguilera D, Araya D, Pailamilla I, Paratori F, Torres-Torres V, Vial PA; Hantavirus Study Group in Chile.

Viruses. 2019 Jul 30;11(8). pii: E693. doi: 10.3390/v11080693.

3.

Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection.

Ribeiro GE, Leon LE, Perez R, Cuiza A, Vial PA, Ferres M, Mertz GJ, Vial C.

Viruses. 2019 Jul 25;11(8). pii: E680. doi: 10.3390/v11080680.

4.

Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.

Jomier F, Bousson V, Viala K, Péréon Y, Magot A, Cauquil C, Bouhour F, Vial C, Bedat-Millet AL, Taithe F, Bresch S, Siri A, Kubis N, Lozeron P.

Eur J Neurol. 2019 Jul 26. doi: 10.1111/ene.14053. [Epub ahead of print]

PMID:
31348848
5.

Development of a P2X1-eYFP receptor knock-in mouse to track receptors in real time.

Mahaut Smith MP, Evans RJ, Vial C.

Purinergic Signal. 2019 Sep;15(3):397-402. doi: 10.1007/s11302-019-09666-1. Epub 2019 Jul 8.

PMID:
31286385
6.

Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.

Svahn J, Laforêt P, Vial C, Streichenberger N, Romero N, Bouchet-Séraphin C, Bruneel A, Dupré T, Seta N, Menassa R, Michel-Calemard L, Stojkovic T.

Neuromuscul Disord. 2019 Jul;29(7):497-502. doi: 10.1016/j.nmd.2019.05.004. Epub 2019 May 9.

PMID:
31266720
7.

FSHD1 and FSHD2 form a disease continuum.

Sacconi S, Briand-Suleau A, Gros M, Baudoin C, Lemmers RJLF, Rondeau S, Lagha N, Nigumann P, Cambieri C, Puma A, Chapon F, Stojkovic T, Vial C, Bouhour F, Cao M, Pegoraro E, Petiot P, Behin A, Marc B, Eymard B, Echaniz-Laguna A, Laforet P, Salviati L, Jeanpierre M, Cristofari G, van der Maarel SM.

Neurology. 2019 May 7;92(19):e2273-e2285. doi: 10.1212/WNL.0000000000007456. Epub 2019 Apr 12.

PMID:
30979860
8.

Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions.

Olivé M, Engvall M, Ravenscroft G, Cabrera-Serrano M, Jiao H, Bortolotti CA, Pignataro M, Lambrughi M, Jiang H, Forrest ARR, Benseny-Cases N, Hofbauer S, Obinger C, Battistuzzi G, Bellei M, Borsari M, Di Rocco G, Viola HM, Hool LC, Cladera J, Lagerstedt-Robinson K, Xiang F, Wredenberg A, Miralles F, Baiges JJ, Malfatti E, Romero NB, Streichenberger N, Vial C, Claeys KG, Straathof CSM, Goris A, Freyer C, Lammens M, Bassez G, Kere J, Clemente P, Sejersen T, Udd B, Vidal N, Ferrer I, Edström L, Wedell A, Laing NG.

Nat Commun. 2019 Mar 27;10(1):1396. doi: 10.1038/s41467-019-09111-2.

9.

A Single-Nucleotide Polymorphism of αVβ₃ Integrin Is Associated with the Andes Virus Infection Susceptibility.

Martínez-Valdebenito C, Angulo J, Le Corre N, Marco C, Vial C, Miquel JF, Cerda J, Mertz G, Vial P, Lopez-Lastra M, Ferrés M.

Viruses. 2019 Feb 20;11(2). pii: E169. doi: 10.3390/v11020169.

10.

Microwave-assisted Organosolv pretreatment of a sawmill mixed feedstock for bioethanol production in a wood biorefinery.

Alio MA, Tugui OC, Vial C, Pons A.

Bioresour Technol. 2019 Mar;276:170-176. doi: 10.1016/j.biortech.2018.12.078. Epub 2018 Dec 24.

PMID:
30623872
11.

Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.

Farinato A, Altamura C, Imbrici P, Maggi L, Bernasconi P, Mantegazza R, Pasquali L, Siciliano G, Lo Monaco M, Vial C, Sternberg D, Carratù MR, Conte D, Desaphy JF.

Pharmacol Res. 2019 Mar;141:224-235. doi: 10.1016/j.phrs.2019.01.004. Epub 2019 Jan 3.

PMID:
30611854
12.

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Laurencin C, Montaut S, Vial C, Bernard L, Bin S, Rascle L, Polo G, Mertens P, Danaila T, Thobois S.

J Neurol Sci. 2018 Sep 15;392:65-68. doi: 10.1016/j.jns.2018.07.004. Epub 2018 Jul 12.

PMID:
30025235
13.

Ankle Strength Impairments in Myotonic Dystrophy Type 1: A Five-Year Follow-up.

Hébert LJ, Vial C, Hogrel JY, Puymirat J.

J Neuromuscul Dis. 2018;5(3):321-330. doi: 10.3233/JND-180311.

PMID:
29889079
14.

Triple-A syndrome: a wide spectrum of adrenal dysfunction.

Roucher-Boulez F, Brac de la Perriere A, Jacquez A, Chau D, Guignat L, Vial C, Morel Y, Nicolino M, Raverot G, Pugeat M.

Eur J Endocrinol. 2018 Mar;178(3):199-207. doi: 10.1530/EJE-17-0642. Epub 2017 Dec 13.

PMID:
29237697
15.

Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.

Rieu I, Degos B, Castelnovo G, Vial C, Durand E, Pereira B, Simonetta-Moreau M, Sangla S, Fluchère F, Guehl D, Burbaud P, Geny C, Gayraud D, Ory-Magne F, Bouhour F, Llinares E, Derost P, Marques A, Durif F.

Parkinsonism Relat Disord. 2018 Jan;46:9-15. doi: 10.1016/j.parkreldis.2017.10.009. Epub 2017 Oct 19.

PMID:
29102441
16.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25.

PMID:
29070644
17.

Structural characterization and rheological behavior of a heteroxylan extracted from Plantago notata Lagasca (Plantaginaceae) seeds.

Benaoun F, Delattre C, Boual Z, Ursu AV, Vial C, Gardarin C, Wadouachi A, Le Cerf D, Varacavoudin T, Ould El-Hadj MD, Michaud P, Pierre G.

Carbohydr Polym. 2017 Nov 1;175:96-104. doi: 10.1016/j.carbpol.2017.07.056. Epub 2017 Jul 23.

PMID:
28917930
18.

Structural characterization and rheological properties of a galactomannan from Astragalus gombo Bunge seeds harvested in Algerian Sahara.

Chouana T, Pierre G, Vial C, Gardarin C, Wadouachi A, Cailleu D, Le Cerf D, Boual Z, Ould El Hadj MD, Michaud P, Delattre C.

Carbohydr Polym. 2017 Nov 1;175:387-394. doi: 10.1016/j.carbpol.2017.08.003. Epub 2017 Aug 7.

PMID:
28917881
19.

Partial microduplication in the histone acetyltransferase complex member KANSL1 is associated with congenital heart defects in 22q11.2 microdeletion syndrome patients.

León LE, Benavides F, Espinoza K, Vial C, Alvarez P, Palomares M, Lay-Son G, Miranda M, Repetto GM.

Sci Rep. 2017 May 11;7(1):1795. doi: 10.1038/s41598-017-01896-w.

20.

Analysis of the variability of food texture properties: Application to the fracturability of dry pet food.

Gouriou B, Bressolette P, Vial C.

J Texture Stud. 2017 Dec;48(6):586-596. doi: 10.1111/jtxs.12269. Epub 2017 May 25.

PMID:
28419511
21.

Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria.

Robert-Varvat F, Jousserand G, Bouhour F, Vial C, Cintas P, Echaniz-Laguna A, Delmont E, Clavelou P, Chauplannaz G, Jomir L, Pereon Y, Leonard-Louis S, Manel V, Antoine JC, Lacour A, Camdessanche JP.

Muscle Nerve. 2018 Feb;57(2):217-221. doi: 10.1002/mus.25666. Epub 2017 Jun 11.

PMID:
28407266
22.

Valorization of carob waste: Definition of a second-generation bioethanol production process.

Bahry H, Pons A, Abdallah R, Pierre G, Delattre C, Fayad N, Taha S, Vial C.

Bioresour Technol. 2017 Jul;235:25-34. doi: 10.1016/j.biortech.2017.03.056. Epub 2017 Mar 11.

PMID:
28351729
23.

High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's disease.

Loizon M, Laurencin C, Vial C, Danaila T, Thobois S.

J Neurol. 2016 Dec;263(12):2416-2418. Epub 2016 Sep 13.

PMID:
27624119
24.

The wide POLG-related spectrum: An integrated view.

Béreau M, Anheim M, Echaniz-Laguna A, Magot A, Verny C, Goideau-Sevrain M, Barth M, Amati-Bonneau P, Allouche S, Ayrignac X, Bédat-Millet AL, Guyant-Maréchal L, Kuntzer T, Ochsner F, Petiot P, Vial C, Omer S, Sole G, Taieb G, Carvalho N, Tio G, Kremer S, Acquaviva-Bourdain C, de Camaret BM, Tranchant C.

J Neurol Sci. 2016 Sep 15;368:70-6. doi: 10.1016/j.jns.2016.06.062. Epub 2016 Jun 29. No abstract available.

PMID:
27538604
25.

High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.

Hachulla E, Benveniste O, Hamidou M, Mouthon L, Schleinitz N, Lozeron P, Léger JM, Vial C, Viala K.

Int J Neurosci. 2017 Jun;127(6):516-523. doi: 10.1080/00207454.2016.1204544. Epub 2016 Jul 14.

PMID:
27412148
26.

[Daring to talk about sexuality with patients].

Vial C.

Rev Infirm. 2016 Jun-Jul;222:27-9. doi: 10.1016/j.revinf.2016.04.006. French.

PMID:
27317819
27.

Impaired P2X1 Receptor-Mediated Adhesion in Eosinophils from Asthmatic Patients.

Wright A, Mahaut-Smith M, Symon F, Sylvius N, Ran S, Bafadhel M, Muessel M, Bradding P, Wardlaw A, Vial C.

J Immunol. 2016 Jun 15;196(12):4877-84. doi: 10.4049/jimmunol.1501585. Epub 2016 May 9.

28.

Accuracy of a Genetic Test for the Diagnosis of Hypolactasia in Chilean Children: Comparison With the Breath Test.

Alliende F, Vial C, Espinoza K, Schnettle D, Romero V, Miquel I, Arancibia ME, Rios G, Rodriguez L, Quesada S, Lucero Y, Repetto GM.

J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):e10-3. doi: 10.1097/MPG.0000000000001208.

PMID:
27035380
29.

Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS.

Oh SJ, Shcherbakova N, Kostera-Pruszczyk A, Alsharabati M, Dimachkie M, Blanco JM, Brannagan T, Lavrnić D, Shieh PB, Vial C, Meisel A, Komoly S, Schoser B, Sivakumar K, So Y; LEMS Study Group.

Muscle Nerve. 2016 May;53(5):717-25. doi: 10.1002/mus.25070. Epub 2016 Mar 3.

PMID:
26852139
30.

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, Bellance R, Bouhour F, Boutte C, Boyer F, Campana-Salort E, Chapon F, Cintas P, Desnuelle C, Deschamps R, Drouin-Garraud V, Ferrer X, Gervais-Bernard H, Ghorab K, Laforet P, Magot A, Magy L, Menard D, Minot MC, Nadaj-Pakleza A, Pellieux S, Pereon Y, Preudhomme M, Pouget J, Sacconi S, Sole G, Stojkovich T, Tiffreau V, Urtizberea A, Vial C, Zagnoli F, Caranhac G, Bourlier C, Riviere G, Geille A, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G.

PLoS One. 2016 Feb 5;11(2):e0148264. doi: 10.1371/journal.pone.0148264. eCollection 2016.

31.

Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres.

Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P; EURECALS consortium.

Eur J Neurol. 2016 Apr;23(4):787-95. doi: 10.1111/ene.12941. Epub 2016 Feb 1.

PMID:
26833536
32.

Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data.

Schramm C, Vial C, Bachoud-Lévi AC, Katsahian S.

Stat Methods Med Res. 2018 Jan;27(1):97-113. doi: 10.1177/0962280215621591. Epub 2015 Dec 31.

PMID:
26721877
33.

Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics.

Vial C, Martinez-Valdebenito C, Rios S, Martinez J, Vial PA, Ferres M, Rivera JC, Perez R, Valdivieso F.

Diagn Microbiol Infect Dis. 2016 Jan;84(1):36-39. doi: 10.1016/j.diagmicrobio.2015.07.019. Epub 2015 Jul 29.

34.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome.

Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P.

Neurology. 2015 Dec 8;85(23):2076-8. doi: 10.1212/WNL.0000000000002037. Epub 2015 Sep 23. No abstract available.

PMID:
26400578
35.

Development of a submerged anaerobic membrane bioreactor for concurrent extraction of volatile fatty acids and biohydrogen production.

Trad Z, Akimbomi J, Vial C, Larroche C, Taherzadeh MJ, Fontaine JP.

Bioresour Technol. 2015 Nov;196:290-300. doi: 10.1016/j.biortech.2015.07.095. Epub 2015 Jul 30.

PMID:
26253913
36.

[Predictive value of conventional immuno-histochemical biomarkers in breast cancer].

Acevedo F, Camus M, Vial C, Panay S, Abarca M, Domínguez F, Sánchez C.

Rev Med Chil. 2015 Jun;143(6):724-32. doi: 10.4067/S0034-98872015000600005. Spanish.

37.

A retrospective study on the efficacy and safety of intraveinous immunoglobulin (Tegeline®) in patients with chronic inflammatory demyelinating polyneuropathy.

Robert F, Edan G, Nicolas G, Pouget J, Vial C, Antoine JC, Puget S.

Presse Med. 2015 Jul-Aug;44(7-8):e291-300. doi: 10.1016/j.lpm.2014.10.021. Epub 2015 Jun 9.

PMID:
26071027
38.

Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice.

Morizot-Koutlidis R, André-Obadia N, Antoine JC, Attarian S, Ayache SS, Azabou E, Benaderette S, Camdessanché JP, Cassereau J, Convers P, d'Anglejean J, Delval A, Durand MC, Etard O, Fayet G, Fournier E, Franques J, Gavaret M, Guehl D, Guerit JM, Krim E, Kubis N, Lacour A, Lozeron P, Mauguière F, Merle PE, Mesrati F, Mutschler V, Nicolas G, Nordine T, Pautot V, Péréon Y, Petiot P, Pouget J, Praline J, Salhi H, Trébuchon A, Tyvaert L, Vial C, Zola JM, Zyss J, Lefaucheur JP.

Neurophysiol Clin. 2015 May;45(2):131-42. doi: 10.1016/j.neucli.2015.04.001. Epub 2015 May 6.

PMID:
25957985
39.

Protein "amyloid-like" networks at the phospholipid membrane formed by 4-hydroxy-2-nonenal-modified mitochondrial creatine kinase.

Maniti O, François-Moutal L, Lecompte MF, Vial C, Lagarde M, Guichardant M, Marcillat O, Granjon T.

Mol Membr Biol. 2015;32(1):1-10. doi: 10.3109/09687688.2015.1023376. Epub 2015 Apr 13.

PMID:
25865250
40.

Genetic structure characterization of Chileans reflects historical immigration patterns.

Eyheramendy S, Martinez FI, Manevy F, Vial C, Repetto GM.

Nat Commun. 2015 Mar 17;6:6472. doi: 10.1038/ncomms7472.

41.

Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.

Salort-Campana E, Nguyen K, Bernard R, Jouve E, Solé G, Nadaj-Pakleza A, Niederhauser J, Charles E, Ollagnon E, Bouhour F, Sacconi S, Echaniz-Laguna A, Desnuelle C, Tranchant C, Vial C, Magdinier F, Bartoli M, Arne-Bes MC, Ferrer X, Kuntzer T, Levy N, Pouget J, Attarian S.

Orphanet J Rare Dis. 2015 Jan 21;10:2. doi: 10.1186/s13023-014-0218-1.

42.

Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies.

Lay-Son G, Espinoza K, Vial C, Rivera JC, Guzmán ML, Repetto GM.

J Pediatr (Rio J). 2015 Mar-Apr;91(2):189-95. doi: 10.1016/j.jped.2014.07.003. Epub 2014 Oct 30.

43.

Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study.

Repetto GM, Guzmán ML, Delgado I, Loyola H, Palomares M, Lay-Son G, Vial C, Benavides F, Espinoza K, Alvarez P.

BMJ Open. 2014 Nov 6;4(11):e005041. doi: 10.1136/bmjopen-2014-005041.

44.

A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.

Vial PA, Valdivieso F, Calvo M, Rioseco ML, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, Bidart T, Cuiza A, Marco C, Hjelle B, Ye C, Hanfelt-Goade D, Vial C, Rivera JC, Delgado I, Mertz GJ; Hantavirus Study Group in Chile.

Antivir Ther. 2015;20(4):377-86. doi: 10.3851/IMP2875. Epub 2014 Oct 15.

PMID:
25316807
45.

Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011.

Martinez-Valdebenito C, Calvo M, Vial C, Mansilla R, Marco C, Palma RE, Vial PA, Valdivieso F, Mertz G, Ferrés M.

Emerg Infect Dis. 2014 Oct;20(10):1629-36. doi: 10.3201/eid2010.140353.

46.

Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function.

Kauffenstein G, Pelletier J, Lavoie EG, Kukulski F, Martín-Satué M, Dufresne SS, Frenette J, Ribas Fürstenau C, Sereda MJ, Toutain B, Henrion D, Sullivan R, Vial C, Sévigny J.

J Biol Chem. 2014 Oct 10;289(41):28629-39. doi: 10.1074/jbc.M114.604082. Epub 2014 Aug 25.

47.

Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease.

Sacconi S, Wahbi K, Theodore G, Garcia J, Salviati L, Bouhour F, Vial C, Duboc D, Laforêt P, Desnuelle C.

Neuromuscul Disord. 2014 Jul;24(7):648-50. doi: 10.1016/j.nmd.2014.04.005. Epub 2014 Apr 24.

PMID:
24844452
48.

Amplification of human platelet activation by surface pannexin-1 channels.

Taylor KA, Wright JR, Vial C, Evans RJ, Mahaut-Smith MP.

J Thromb Haemost. 2014 Jun;12(6):987-98. doi: 10.1111/jth.12566.

49.

Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis.

Petruzzo P, Gazarian A, Kanitakis J, Parmentier H, Guigal V, Guillot M, Vial C, Dubernard JM, Morelon E, Badet L.

Ann Surg. 2015 Jan;261(1):213-20. doi: 10.1097/SLA.0000000000000627.

PMID:
24646555
50.

Supplemental Content

Support Center